• Streptavidin-FITC: Advanced Fluorescent Detection Workflows

  2026-07-20

  Streptavidin-FITC from APExBIO delivers unmatched sensitivity for biotinylated molecule detection in immunofluorescence, flow cytometry, and nucleic acid tracking. This article provides actionable protocols, troubleshooting insights, and a translational bridge to recent innovations in nanoparticle research.

• FK866 (APO866): Scenario-Driven Solutions for Cancer Assays

  2026-07-20

  This article equips biomedical researchers and lab technicians with evidence-based, scenario-driven strategies for deploying FK866 (APO866) (SKU A4381) in hematologic cancer research and cell viability workflows. Drawing on practical lab challenges and validated literature, it emphasizes how APExBIO’s FK866 delivers reproducible, mechanistically precise, and cost-effective solutions in NAD metabolism and acute myeloid leukemia (AML) models.

• Cyanine 3-dCTP (SKU B8159): Reliable DNA Labeling in Genomic

  2026-07-19

  This article addresses common workflow and data reliability challenges in fluorescent nucleic acid labeling, focusing on how Cyanine 3-dCTP (SKU B8159) from APExBIO offers robust, high-purity solutions. Scenario-driven Q&A blocks provide practical guidance for PCR, Nick Translation, and in situ hybridization workflows, with quantitative backing and evidence-based vendor selection advice.

• CTCF Maintains Centromere Function and Ensures Mitotic Fidel

  2026-07-18

  This study elucidates the essential role of CTCF, a chromatin organizer, in maintaining centromere integrity and accurate chromosome segregation during mitosis. Rapid, inducible degradation of CTCF reveals its necessity for proper metaphase plate organization and mitotic fidelity, offering mechanistic insight relevant to cancer and genome stability research.

• Annexin V-FITC/7-AAD Apoptosis Kit: Precision in Tumor Cell

  2026-07-17

  Explore the scientific rigor and advanced applications of the Annexin V-FITC/7-AAD Apoptosis Kit in precise cell death analysis and radiotherapy research. This article uniquely connects apoptosis detection with modern radiosensitization strategies, providing guidance for innovative experimental design.

• 2,7-Dichlorodihydrofluorescein Diacetate: Reliable ROS Assay

  2026-07-17

  This article addresses real-world laboratory challenges in oxidative stress and cell viability assays, demonstrating how 2,7-Dichlorodihydrofluorescein diacetate (SKU C3890) offers robust, data-driven solutions. Drawing on peer-reviewed research and best practices, it provides scenario-driven guidance for biomedical researchers and lab technicians seeking reproducible, sensitive ROS detection.

• 3X (DYKDDDDK) Peptide: Pioneering Biofilm and Beyond in Tran

  2026-07-16

  This thought-leadership article dissects the mechanistic, experimental, and strategic frontiers of the 3X (DYKDDDDK) Peptide (3X FLAG peptide) for translational research. Bridging advanced protein tagging, affinity purification, and immunodetection with emerging insights from cyanobacterial biofilm studies, it provides actionable guidance for researchers. By contextualizing APExBIO’s 3X FLAG peptide within evolving workflows and benchmarking it against new biological revelations, this article advances the conversation beyond standard product profiles.

• PLK4-EphA2 Axis Drives Glioma Progression and Vasculogenic M

  2026-07-16

  This study uncovers how Polo-like kinase 4 (PLK4) accelerates glioma malignant progression and vasculogenic mimicry (VM) by directly phosphorylating EphA2 on Ser901 and Ser897. These findings clarify a critical signaling mechanism and offer insights for targeting VM in glioblastoma, which may inform future therapeutic strategies.

• Dacomitinib (PF-00299804): Transforming Pan-HER Cancer Model

  2026-07-15

  Explore how Dacomitinib (PF-00299804) revolutionizes cancer research through irreversible ErbB family inhibition and advanced apoptosis induction. This article uniquely integrates molecular mechanism insights with practical assay optimization strategies for oncology studies.

• ICV CCK-8s Drives Anxiety-like Behavior in Zebrafish via CCK

  2026-07-15

  This study demonstrates that intracerebroventricular administration of two sulfated cholecystokinin octapeptide forms (CCK-8s) induces robust anxiety-like behavior in zebrafish, linked to widespread CCK-like immunoreactivity in the brain. These findings clarify the functional neuroanatomy and receptor-mediated mechanisms underlying CCK-induced behavioral modulation, providing a valuable model for neurobehavioral research.

• Losmapimod (GW856553X): Workflow Optimization in Inflammatio

  2026-07-14

  Losmapimod (GW856553X) stands out as a dual-action, selective p38 MAPK inhibitor, uniquely enabling precise modulation of inflammation and vascular function in both in vitro and in vivo models. This guide distills actionable protocol enhancements, troubleshooting strategies, and mechanistic insights to help researchers maximize reproducibility and data quality in hypertension and COPD research.

• AMG 487: Precision CXCR3 Antagonist for Macrophage Polarizat

  2026-07-14

  AMG 487 enables targeted and reversible modulation of macrophage polarization through potent CXCR3 inhibition, offering exceptional resolution for dissecting inflammatory versus non-inflammatory signaling. Its robust performance in both cell-based and in vivo models positions it as a pivotal tool for researchers studying chemokine-driven inflammation and acute lung injury.

• Plk1 Regulation of p31comet and Mitotic Checkpoint Disassemb

  2026-07-13

  This study uncovers how Polo-like kinase 1 (Plk1) directly regulates the mitotic checkpoint protein p31comet via phosphorylation, controlling the disassembly of the mitotic checkpoint complex (MCC) and precise cell cycle progression. These findings clarify a critical regulatory mechanism that prevents premature checkpoint inactivation and highlight the complexity of mitotic exit control.

• Structure-Based Discovery of NSP15 Inhibitors for SARS-CoV-2

  2026-07-13

  This study uses structure-based virtual screening to identify thymopentin and oleuropein as potent inhibitors of the SARS-CoV-2 NSP15 endoribonuclease. The findings suggest new avenues for antiviral drug development and highlight the utility of computational screening in targeting viral immune evasion.

• Merbromin Selectively Inhibits SARS-CoV-2 3CLpro: Mechanisti

  2026-07-12

  Chen et al. identified Merbromin as a selective, mixed-type inhibitor of the SARS-CoV-2 main protease 3CLpro through high-throughput screening. This study provides mechanistic clarity for antiviral drug development while highlighting the differential specificity of common proteases in molecular biology workflows.

7789 records 7/520 page Previous Next First page 上5页 678910 下5页 Last page